<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39321169</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>9</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Incidence trends of gastric cancer in the United States over 2000-2020: A population-based analysis.</ArticleTitle><Pagination><StartPage>e0310040</StartPage><MedlinePgn>e0310040</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0310040</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0310040</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Gastric cancer ranks among the top cancers in terms of both occurrence and death rates in the United States (US). Our objective was to provide the incidence trends of gastric cancer in the US from 2000 to 2020 by age, sex, histology, and race/ethnicity, and to evaluate the effects of the COVID-19 pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We obtained data from the Surveillance, Epidemiology, and End Results 22 program. The morphologies of gastric cancer were classified as adenocarcinoma, gastrointestinal stromal tumor, signet ring cell carcinoma, and carcinoid tumor. We used average annual percent change (AAPC) and compared pairs using parallelism and coincidence. The numbers were displayed as both counts and age-standardized incidence rates (ASIRs) per 100000 individuals, along with their corresponding 95% confidence intervals (CIs).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Over 2000-2019, most gastric cancers were among those aged ≥55 years (81.82%), men (60.37%), and Non-Hispanic Whites (62.60%). By histology, adenocarcinoma had the highest incident cases. During the COVID-19 pandemic, there was a remarkable decline in ASIRs of gastric cancer in both sexes and all races (AAPC: -8.92; 95% CI: -11.18 to -6.67). The overall incidence trends of gastric cancer were not parallel, nor identical.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The incidence of gastric cancer shows notable variations by age, race, and sex, with a rising trend across ethnicities. While the overall incidence has declined, a noteworthy increase has been observed among younger adults, particularly young Hispanic women; however, rates decreased significantly in 2020.</AbstractText><CopyrightInformation>Copyright: © 2024 Aslani et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aslani</LastName><ForeName>Armin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soheili</LastName><ForeName>Amirali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mousavi</LastName><ForeName>Seyed Ehsan</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0003-4747-5639</Identifier><AffiliationInfo><Affiliation>Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebrahimi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antar</LastName><ForeName>Ryan Michael</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>The George Washington University School of Medicine &amp; Health Sciences, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yekta</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Calaveras County Department of Health, Calaveras County, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nejadghaderi</LastName><ForeName>Seyed Aria</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-8692-9720</Identifier><AffiliationInfo><Affiliation>HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systematic Review and Meta‑analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="Y">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018426" MajorTopicYN="Y">SEER Program</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39321169</ArticleId><ArticleId IdType="pmc">PMC11423999</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0310040</ArticleId><ArticleId IdType="pii">PONE-D-24-21194</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38. Epub 20181128. doi: 10.5114/pg.2018.80001 ; PubMed Central PMCID: PMC6444111.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pg.2018.80001</ArticleId><ArticleId IdType="pmc">PMC6444111</ArticleId><ArticleId IdType="pubmed">30944675</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al.. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. Epub 20210204. doi: 10.3322/caac.21660 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21660</ArticleId><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Cancer Statistics Data Visualizations Tool, based on 2022 submission data (1999–2020) [Internet]. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Available from: https://www.cdc.gov/cancer/dataviz, released in June 2023.</Citation></Reference><Reference><Citation>SEER Cancer Stat Facts: Stomach Cancer [cited 2024 June 24]. Available from: https://seer.cancer.gov/statfacts/html/stomach.html.</Citation></Reference><Reference><Citation>Balakrishnan M, George R, Sharma A, Graham DY. Changing Trends in Stomach Cancer Throughout the World. Curr Gastroenterol Rep. 2017;19(8):36. doi: 10.1007/s11894-017-0575-8 ; PubMed Central PMCID: PMC6918953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11894-017-0575-8</ArticleId><ArticleId IdType="pmc">PMC6918953</ArticleId><ArticleId IdType="pubmed">28730504</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3(3):251–61. doi: 10.3978/j.issn.2078-6891.2012.021 ; PubMed Central PMCID: PMC3418539.</Citation><ArticleIdList><ArticleId IdType="doi">10.3978/j.issn.2078-6891.2012.021</ArticleId><ArticleId IdType="pmc">PMC3418539</ArticleId><ArticleId IdType="pubmed">22943016</ArticleId></ArticleIdList></Reference><Reference><Citation>Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int J Mol Sci. 2020;21(11):4012. Epub 20200604. doi: 10.3390/ijms21114012 ; PubMed Central PMCID: PMC7312039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21114012</ArticleId><ArticleId IdType="pmc">PMC7312039</ArticleId><ArticleId IdType="pubmed">32512697</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkatout I, Biebl M, Momenimovahed Z, Giovannucci E, Hadavandsiri F, Salehiniya H, et al.. Has COVID-19 Affected Cancer Screening Programs? A Systematic Review. Front Oncol. 2021;11:675038. Epub 2021/06/04. doi: 10.3389/fonc.2021.675038 ; PubMed Central PMCID: PMC8165307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.675038</ArticleId><ArticleId IdType="pmc">PMC8165307</ArticleId><ArticleId IdType="pubmed">34079764</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Kok JH, Parmar C, Bangash AH, Samadov E, Demirli Atici S, Cheruvu CV, et al.. Global impact of COVID-19 pandemic on gastric cancer patients. Eur J Surg Oncol. 2023;49(4):876–7. Epub 20230302. doi: 10.1016/j.ejso.2023.02.016 ; PubMed Central PMCID: PMC9977693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2023.02.016</ArticleId><ArticleId IdType="pmc">PMC9977693</ArticleId><ArticleId IdType="pubmed">36898901</ArticleId></ArticleIdList></Reference><Reference><Citation>Hesary FB, Salehiniya H. The Impact of the COVID-19 Epidemic on Diagnosis, Treatment, Concerns, Problems, and Mental Health in Patients with Gastric Cancer. Journal of Gastrointestinal Cancer. 2022;53(3):797–804. doi: 10.1007/s12029-021-00692-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12029-021-00692-0</ArticleId><ArticleId IdType="pmc">PMC8438101</ArticleId><ArticleId IdType="pubmed">34519975</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita S, Sakuramoto S, Miyawaki Y, Morimoto Y, Ebara G, Nishibeppu K, et al.. Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in Japan. Int J Clin Oncol. 2022;27(5):930–9. Epub 20220328. doi: 10.1007/s10147-022-02142-8 ; PubMed Central PMCID: PMC8958809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10147-022-02142-8</ArticleId><ArticleId IdType="pmc">PMC8958809</ArticleId><ArticleId IdType="pubmed">35344118</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, et al.. The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study. EClinicalMedicine. 2022;47:101404. Epub 20220421. doi: 10.1016/j.eclinm.2022.101404 ; PubMed Central PMCID: PMC9046108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101404</ArticleId><ArticleId IdType="pmc">PMC9046108</ArticleId><ArticleId IdType="pubmed">35497064</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Chen K, Hou H, Li W, Wang X, Dao Q, et al.. Incidence and mortality trends in gastric cancer in the United States, 1992–2019. Int J Cancer. 2023;152(9):1827–36. Epub 20230103. doi: 10.1002/ijc.34415 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.34415</ArticleId><ArticleId IdType="pubmed">36562305</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson WF, Rabkin CS, Turner N, Fraumeni JF Jr., Rosenberg PS, Camargo MC. The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites. J Natl Cancer Inst. 2018;110(6):608–15. doi: 10.1093/jnci/djx262 ; PubMed Central PMCID: PMC6005150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djx262</ArticleId><ArticleId IdType="pmc">PMC6005150</ArticleId><ArticleId IdType="pubmed">29361173</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, El-Serag HB, Thrift AP. Increasing Incidence of Advanced Non-cardia Gastric Cancers Among Younger Hispanics in the USA. Digestive Diseases and Sciences. 2021;66(5):1669–72. doi: 10.1007/s10620-020-06397-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-020-06397-x</ArticleId><ArticleId IdType="pubmed">32548813</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C-T, Zeng L, Yang J, Zeng C, Chen Y. Analysis of the incidence and survival of gastric cancer based on the lauren classification: a large population-based study using SEER. Frontiers in Oncology. 2020;10:1212. doi: 10.3389/fonc.2020.01212</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.01212</ArticleId><ArticleId IdType="pmc">PMC7416646</ArticleId><ArticleId IdType="pubmed">32850357</ArticleId></ArticleIdList></Reference><Reference><Citation>Rustgi SD, McKinley M, McBay B, Zylberberg HM, Gomez SL, Hur C, et al.. Epidemiology of Gastric Malignancies 2000–2018 According to Histology: A Population-Based Analysis of Incidence and Temporal Trends. Clinical Gastroenterology and Hepatology. 2023. doi: 10.1016/j.cgh.2023.01.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2023.01.037</ArticleId><ArticleId IdType="pmc">PMC10809276</ArticleId><ArticleId IdType="pubmed">36792000</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME. The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship. Am J Surg Pathol. 2016;40(12):e94–e102. doi: 10.1097/PAS.0000000000000749 ; PubMed Central PMCID: PMC5106320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PAS.0000000000000749</ArticleId><ArticleId IdType="pmc">PMC5106320</ArticleId><ArticleId IdType="pubmed">27740970</ArticleId></ArticleIdList></Reference><Reference><Citation>SEER. About the SEER Program ‐ SEER. Retrieved Jun 11, 2023, from https://seer.cancer.gov/about/overview.html.</Citation></Reference><Reference><Citation>databse TNCIsS. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence ‐ SEER Research Limited-Field Data with Delay-Adjustment, 22 Registries, Malignant Only, Nov 2022 Sub (2000–2020) ‐ Linked To County Attributes ‐ Time Dependent (1990–2021) Income/Rurality, 1969–2021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission.</Citation></Reference><Reference><Citation>databse TNCIsS. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence ‐ SEER Research Limited-Field Data, 22 Registries, Nov 2022 Sub (2000–2020) ‐ Linked To County Attributes ‐ Time Dependent (1990–2021) Income/Rurality, 1969–2021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission.</Citation></Reference><Reference><Citation>SEER. SEER Research Data Agreement. (n.d.). SEER. Retrieved Jun 11, 2023, from https://seer.cancer.gov/data-software/documentation/seerstat/nov2022/seer-dua-nov2022.html.</Citation></Reference><Reference><Citation>Institute TNC. Impact of COVID on 2020 SEER Cancer Incidence Data. 2023.</Citation></Reference><Reference><Citation>SEER. Surveillance Research Program, National Cancer Institute SEER*Stat software (seer.cancer.gov/seerstat) version 8.4.1.2.</Citation></Reference><Reference><Citation>Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002;94(20):1537–45. doi: 10.1093/jnci/94.20.1537 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/94.20.1537</ArticleId><ArticleId IdType="pubmed">12381706</ArticleId></ArticleIdList></Reference><Reference><Citation>Technical Notes ‐ Reporting Delay. In: Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK, editors. SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD, based on November 2009 SEER data submission, posted to the SEER website, 2010. pp 12–16. [View PDF (PDF)].</Citation></Reference><Reference><Citation>Institute TNC. Development of the Delay Model. 2023.</Citation></Reference><Reference><Citation>Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15(6):547–69. doi: 10.1177/0962280206070621 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280206070621</ArticleId><ArticleId IdType="pubmed">17260923</ArticleId></ArticleIdList></Reference><Reference><Citation>Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28(29):3670–82. doi: 10.1002/sim.3733 ; PubMed Central PMCID: PMC2843083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3733</ArticleId><ArticleId IdType="pmc">PMC2843083</ArticleId><ArticleId IdType="pubmed">19856324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ. Comparability of segmented line regression models. Biometrics. 2004;60(4):1005–14. doi: 10.1111/j.0006-341X.2004.00256.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0006-341X.2004.00256.x</ArticleId><ArticleId IdType="pubmed">15606421</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Chen HS, Byrne J, Wheeler B, Feuer EJ. Twenty years since Joinpoint 1.0: Two major enhancements, their justification, and impact. Stat Med. 2022;41(16):3102–30. Epub 20220506. doi: 10.1002/sim.9407 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.9407</ArticleId><ArticleId IdType="pubmed">35522060</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute NC. Joinpoint Regression Program, Version 5.0.2 ‐ May 2023; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute.</Citation></Reference><Reference><Citation>Institute TNC. Weighted BIC (WBIC).</Citation></Reference><Reference><Citation>Kim HJ, Luo J, Chen HS, Green D, Buckman D, Byrne J, et al.. Improved confidence interval for average annual percent change in trend analysis. Stat Med. 2017;36(19):3059–74. Epub 20170605. doi: 10.1002/sim.7344 ; PubMed Central PMCID: PMC5652079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7344</ArticleId><ArticleId IdType="pmc">PMC5652079</ArticleId><ArticleId IdType="pubmed">28585245</ArticleId></ArticleIdList></Reference><Reference><Citation>Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. Journal of surgical oncology. 2013;107(3):230–6. doi: 10.1002/jso.23262</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.23262</ArticleId><ArticleId IdType="pubmed">23129495</ArticleId></ArticleIdList></Reference><Reference><Citation>Thrift AP, El-Serag HB. Burden of gastric cancer. Clinical Gastroenterology and Hepatology. 2020;18(3):534–42. doi: 10.1016/j.cgh.2019.07.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2019.07.045</ArticleId><ArticleId IdType="pmc">PMC8859863</ArticleId><ArticleId IdType="pubmed">31362118</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah SC, Halvorson AE, Lee D, Bustamante R, McBay B, Gupta R, et al.. Helicobacter pylori Burden in the United States According to Individual Demographics and Geography: A Nationwide Analysis of the Veterans Healthcare System. Clinical Gastroenterology and Hepatology. 2024;22(1):42–50.e26. doi: 10.1016/j.cgh.2023.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2023.05.016</ArticleId><ArticleId IdType="pubmed">37245717</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y-C, Malfertheiner P, Yu H-T, Kuo C-L, Chang Y-Y, Meng F-T, et al.. Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022. Gastroenterology. 2024. doi: 10.1053/j.gastro.2023.12.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2023.12.022</ArticleId><ArticleId IdType="pubmed">38176660</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, He F, Clifford GM, Li M, Fan Z, Li X, et al.. A systematic review and meta-analysis on the relative and attributable risk of Helicobacter pylori infection and cardia and non-cardia gastric cancer. Expert Review of Molecular Diagnostics. 2023;23(12):1251–61. doi: 10.1080/14737159.2023.2277377</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737159.2023.2277377</ArticleId><ArticleId IdType="pubmed">37905778</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulten KG, Lamberth LB, Kalfus IN, Graham DY. National and Regional US Antibiotic Resistance to Helicobacter pylori: Lessons From a Clinical Trial. Gastroenterology. 2021;161(1):342–4.e1. doi: 10.1053/j.gastro.2021.03.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.03.045</ArticleId><ArticleId IdType="pmc">PMC8267964</ArticleId><ArticleId IdType="pubmed">33798524</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S, Cappell K, Sedgley R, Pelletier C, Jacob R, Bonafede M, et al.. Diagnosis and treatment patterns among patients with newly diagnosed Helicobacter pylori infection in the United States 2016–2019. Scientific Reports. 2023;13(1):1375. doi: 10.1038/s41598-023-28200-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-28200-3</ArticleId><ArticleId IdType="pmc">PMC9876904</ArticleId><ArticleId IdType="pubmed">36697470</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: a cancer journal for clinicians. 2013;63(1):11–30. doi: 10.3322/caac.21166</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21166</ArticleId><ArticleId IdType="pubmed">23335087</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui FH, Tuan B, Swenson SL, Wong RJ. Ethnic Disparities in Gastric Cancer Incidence and Survival in the USA: An Updated Analysis of 1992–2009 SEER Data. Digestive Diseases and Sciences. 2014;59(12):3027–34. doi: 10.1007/s10620-014-3275-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-014-3275-3</ArticleId><ArticleId IdType="pubmed">25030941</ArticleId></ArticleIdList></Reference><Reference><Citation>IARC Helicobacter pylori Working Group. Helicobacter pylori eradication as a strategy for preventing gastric cancer. Lyon (France): International Agency for Research on Cancer (IARC Working Group Reports, No. 8); 2014. Available at: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/index.php.</Citation></Reference><Reference><Citation>Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M, Kavosi Z. Risk Factors for Gastric Cancer: A Systematic Review. Asian Pac J Cancer Prev. 2018;19(3):591–603. Epub 2018/03/28. doi: 10.22034/APJCP.2018.19.3.591 ; PubMed Central PMCID: PMC5980829.</Citation><ArticleIdList><ArticleId IdType="doi">10.22034/APJCP.2018.19.3.591</ArticleId><ArticleId IdType="pmc">PMC5980829</ArticleId><ArticleId IdType="pubmed">29579788</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitsma MB, Kendrick PJ, Ababneh E, Abbafati C, Abbasi-Kangevari M, Abdoli A, et al.. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet. 2021;397(10292):2337–60. doi: 10.1016/S0140-6736(21)01169-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01169-7</ArticleId><ArticleId IdType="pmc">PMC8223261</ArticleId><ArticleId IdType="pubmed">34051883</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang FF, Cudhea F, Shan Z, Michaud DS, Imamura F, Eom H, et al.. Preventable Cancer Burden Associated With Poor Diet in the United States. JNCI Cancer Spectrum. 2019;3(2):pkz034. doi: 10.1093/jncics/pkz034</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jncics/pkz034</ArticleId><ArticleId IdType="pmc">PMC6649723</ArticleId><ArticleId IdType="pubmed">31360907</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah SC, Boffetta P, Johnson KC, Hu J, Palli D, Ferraroni M, et al.. Occupational exposures and odds of gastric cancer: a StoP project consortium pooled analysis. International Journal of Epidemiology. 2020;49(2):422–34. doi: 10.1093/ije/dyz263</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyz263</ArticleId><ArticleId IdType="pmc">PMC10507679</ArticleId><ArticleId IdType="pubmed">31965145</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Liu X, Cheng W, Li H, Zhang D. The global, regional and national burden of stomach cancer and its attributable risk factors from 1990 to 2019. Sci Rep. 2022;12(1):11542. Epub 2022/07/08. doi: 10.1038/s41598-022-15839-7 ; PubMed Central PMCID: PMC9262989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15839-7</ArticleId><ArticleId IdType="pmc">PMC9262989</ArticleId><ArticleId IdType="pubmed">35798837</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean MH, El-Omar EM. Genetics of gastric cancer. Nature Reviews Gastroenterology &amp; Hepatology. 2014;11(11):664–74. doi: 10.1038/nrgastro.2014.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2014.143</ArticleId><ArticleId IdType="pubmed">25134511</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang RJ, Epplein M, Hamashima C, Choi IJ, Lee E, Deapen D, et al.. An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States. Clinical Gastroenterology and Hepatology. 2022;20(10):2218–28.e2. doi: 10.1016/j.cgh.2021.09.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2021.09.039</ArticleId><ArticleId IdType="pmc">PMC8983795</ArticleId><ArticleId IdType="pubmed">34624563</ArticleId></ArticleIdList></Reference><Reference><Citation>CancerDisparitiesProgressReport.org [Internet]. American Association for Cancer Research. 2020. Available at: http://www.CancerDisparitiesProgressReport.org/. Accessed January 11, 2021.</Citation></Reference><Reference><Citation>Florea A, Brown HE, Harris RB, Oren E. Ethnic disparities in gastric cancer presentation and screening practice in the United States: analysis of 1997–2010 surveillance, epidemiology, and end results-medicare data. Cancer Epidemiology, Biomarkers &amp; Prevention. 2019;28(4):659–65. doi: 10.1158/1055-9965.EPI-18-0471</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-18-0471</ArticleId><ArticleId IdType="pmc">PMC10842639</ArticleId><ArticleId IdType="pubmed">30914435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Graham DY, Khan A, Balakrishnan M, Abrams HR, El-Serag HB, et al.. Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis. Int J Epidemiol. 2018;47(3):966–75. doi: 10.1093/ije/dyy055 ; PubMed Central PMCID: PMC6005108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy055</ArticleId><ArticleId IdType="pmc">PMC6005108</ArticleId><ArticleId IdType="pubmed">29672681</ArticleId></ArticleIdList></Reference><Reference><Citation>Islami F, DeSantis CE, Jemal A. Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997–2014. Clinical Gastroenterology and Hepatology. 2019;17(3):429–39. doi: 10.1016/j.cgh.2018.05.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2018.05.044</ArticleId><ArticleId IdType="pubmed">29902641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang ET, Gomez SL, Fish K, Schupp CW, Parsonnet J, DeRouen MC, et al.. Gastric Cancer Incidence among Hispanics in California: Patterns by Time, Nativity, and Neighborhood Characteristics. Cancer Epidemiology, Biomarkers &amp; Prevention. 2012;21(5):709–19. doi: 10.1158/1055-9965.EPI-11-1208</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-11-1208</ArticleId><ArticleId IdType="pmc">PMC5739914</ArticleId><ArticleId IdType="pubmed">22374991</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Gu J, Ajani JA, Chang DW, Wu X, Stroehlein JR. Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study. Cancer. 2014;120(19):3040–8. Epub 20140624. doi: 10.1002/cncr.28792 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.28792</ArticleId><ArticleId IdType="pubmed">24962126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SC, Yeu Y, Hammer STG, Xiao S, Zhu M, Hong C, et al.. Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants. Cancer Res. 2020;80(11):2114–24. Epub 20200408. doi: 10.1158/0008-5472.CAN-19-2918 ; PubMed Central PMCID: PMC7489496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-19-2918</ArticleId><ArticleId IdType="pmc">PMC7489496</ArticleId><ArticleId IdType="pubmed">32269045</ArticleId></ArticleIdList></Reference><Reference><Citation>Merchant SJ, Kim J, Choi AH, Sun V, Chao J, Nelson R. A rising trend in the incidence of advanced gastric cancer in young Hispanic men. Gastric Cancer. 2017;20(2):226–34. doi: 10.1007/s10120-016-0603-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10120-016-0603-7</ArticleId><ArticleId IdType="pmc">PMC5630456</ArticleId><ArticleId IdType="pubmed">26924751</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy DM. Proton pump inhibitor use, hypergastrinemia, and gastric carcinoids—what is the relationship? International journal of molecular sciences. 2020;21(2):662. doi: 10.3390/ijms21020662</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21020662</ArticleId><ArticleId IdType="pmc">PMC7014182</ArticleId><ArticleId IdType="pubmed">31963924</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi W, Warner RR, Chan DL, Singh S, Segelov E, Strosberg J, et al.. Long-term outcomes of gastroenteropancreatic neuroendocrine tumors. Pancreas. 2018;47(3):321–5. doi: 10.1097/MPA.0000000000001005</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPA.0000000000001005</ArticleId><ArticleId IdType="pubmed">29401168</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenti MV, Rugge M, Lahner E, Miceli E, Toh B-H, Genta RM, et al.. Autoimmune gastritis. Nature Reviews Disease Primers. 2020;6(1):56. doi: 10.1038/s41572-020-0187-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-020-0187-8</ArticleId><ArticleId IdType="pubmed">32647173</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson WF, Rabkin CS, Turner N, Fraumeni JF Jr., Rosenberg PS, Camargo MC. The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites. JNCI: Journal of the National Cancer Institute. 2018;110(6):608–15. doi: 10.1093/jnci/djx262</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djx262</ArticleId><ArticleId IdType="pmc">PMC6005150</ArticleId><ArticleId IdType="pubmed">29361173</ArticleId></ArticleIdList></Reference><Reference><Citation>Montminy EM, Zhou M, Maniscalco L, Abualkhair W, Kim MK, Siegel RL, et al.. Contributions of adenocarcinoma and carcinoid tumors to early-onset colorectal cancer incidence rates in the United States. Annals of internal medicine. 2021;174(2):157–66. doi: 10.7326/M20-0068</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-0068</ArticleId><ArticleId IdType="pubmed">33315473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K, Suh M, Jun JK, Choi KS. Impact of the COVID-19 Pandemic on Gastric Cancer Screening in South Korea: Results From the Korean National Cancer Screening Survey (2017–2021). J Gastric Cancer. 2022;22(4):264–72. doi: 10.5230/jgc.2022.22.e36 ; PubMed Central PMCID: PMC9633925.</Citation><ArticleIdList><ArticleId IdType="doi">10.5230/jgc.2022.22.e36</ArticleId><ArticleId IdType="pmc">PMC9633925</ArticleId><ArticleId IdType="pubmed">36316105</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H, Seo SH, Park JH, Yoo SH, Keam B, Shin A. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea. Epidemiol Health. 2022;44:e2022053. Epub 20220621. doi: 10.4178/epih.e2022053 ; PubMed Central PMCID: PMC9754922.</Citation><ArticleIdList><ArticleId IdType="doi">10.4178/epih.e2022053</ArticleId><ArticleId IdType="pmc">PMC9754922</ArticleId><ArticleId IdType="pubmed">35760396</ArticleId></ArticleIdList></Reference><Reference><Citation>Malagón T, Yong JHE, Tope P, Miller WH Jr., Franco EL. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada. Int J Cancer. 2022;150(8):1244–54. Epub 20211203. doi: 10.1002/ijc.33884 ; PubMed Central PMCID: PMC9015510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.33884</ArticleId><ArticleId IdType="pmc">PMC9015510</ArticleId><ArticleId IdType="pubmed">34843106</ArticleId></ArticleIdList></Reference><Reference><Citation>Seker A, Ozdemir G, Sozutek A, Olmez T, Ozer N, Sahin A, et al.. Gastric cancer diagnosis and staging in coronavirus disease 2019 (Covid-19) pandemic. Ann Ital Chir. 2023;94:203–8. .</Citation><ArticleIdList><ArticleId IdType="pubmed">36606448</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Freha N, Hizkiya R, Abu-Abed M, Michael T, Jacob BM, Rouvinov K, et al.. The impact of the COVID-19 pandemic on colorectal and gastric cancer diagnosis, disease stage and mortality. Front Med (Lausanne). 2022;9:954878. Epub 20220926. doi: 10.3389/fmed.2022.954878 ; PubMed Central PMCID: PMC9548695.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.954878</ArticleId><ArticleId IdType="pmc">PMC9548695</ArticleId><ArticleId IdType="pubmed">36226153</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeki H, Shirabe K, Miyazaki T, Ogawa T, Makita F, Shitara Y, et al.. Decreased numbers of gastric, colorectal, lung, and breast cancer surgeries performed in 17 cancer-designated hospitals in Gunma Prefecture of Japan during the COVID-19 pandemic. Surg Today. 2022;52(12):1714–20. Epub 20220415. doi: 10.1007/s00595-022-02501-y ; PubMed Central PMCID: PMC9010936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00595-022-02501-y</ArticleId><ArticleId IdType="pmc">PMC9010936</ArticleId><ArticleId IdType="pubmed">35426582</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Bai H, Qiao H, Du C, Yao P, Zhang Y, et al.. Causal effects of COVID-19 on cancer risk: A Mendelian randomization study. J Med Virol. 2023;95(4):e28722. doi: 10.1002/jmv.28722 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28722</ArticleId><ArticleId IdType="pubmed">37185860</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F, Dai Z, Huang C, Chen H, Wang X, Li X. Gastrointestinal Disease and COVID-19: A Review of Current Evidence. Dig Dis. 2022;40(4):506–14. Epub 20210910. doi: 10.1159/000519412 ; PubMed Central PMCID: PMC8678221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000519412</ArticleId><ArticleId IdType="pmc">PMC8678221</ArticleId><ArticleId IdType="pubmed">34510032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Drakoulis N, et al.. Contributing factors common to COVID‑19 and gastrointestinal cancer. Oncol Rep. 2022;47(1). Epub 20211115. doi: 10.3892/or.2021.8227 ; PubMed Central PMCID: PMC8611322.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2021.8227</ArticleId><ArticleId IdType="pmc">PMC8611322</ArticleId><ArticleId IdType="pubmed">34779496</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto M, Yamaoka Y, Shirai N, Furuta T. Role of renin-angiotensin system in gastric oncogenesis. J Gastroenterol Hepatol. 2012;27(3):442–51. Epub 2011/11/26. doi: 10.1111/j.1440-1746.2011.06964.x ; PubMed Central PMCID: PMC3739298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1746.2011.06964.x</ArticleId><ArticleId IdType="pmc">PMC3739298</ArticleId><ArticleId IdType="pubmed">22114933</ArticleId></ArticleIdList></Reference><Reference><Citation>Balamtekin N, Artuk C, Arslan M, Gülşen M. The Effect of Helicobacter pylori on the Presentation and Clinical Course of Coronavirus Disease 2019 Infection. J Pediatr Gastroenterol Nutr. 2021;72(4):511–3. doi: 10.1097/MPG.0000000000003005 ; PubMed Central PMCID: PMC7984630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0000000000003005</ArticleId><ArticleId IdType="pmc">PMC7984630</ArticleId><ArticleId IdType="pubmed">33306581</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal A, Ghazy RM, Sherief D, Ismail A, Ellakany WI. Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial. BMC Infect Dis. 2023;23(1):36. Epub 20230120. doi: 10.1186/s12879-023-07993-8 ; PubMed Central PMCID: PMC9854408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-07993-8</ArticleId><ArticleId IdType="pmc">PMC9854408</ArticleId><ArticleId IdType="pubmed">36670359</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekmektzoglou K, Tziatzios G, Siau K, Pawlak KM, Rokkas T, Triantafyllou K, et al.. Covid-19: exploring the "new normal" in gastroenterology training. Acta Gastroenterol Belg. 2021;84(4):627–35. Epub 2021/12/30. doi: 10.51821/84.4.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.51821/84.4.014</ArticleId><ArticleId IdType="pubmed">34965045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>